ArticlePharmaceutical research2021

Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772.

Debra J Tompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.